WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: 20131126_Belatacept_cmap, increased can be thresholded at elevated post-transplant, Acute rejection events are confirmed by biopsy, kidney transplant treatments have been associated with PTLD (post-transplant lymphoproliferative disorder), Gender can be Female, Demographics include Recipient EBV serology, Demographics include Geographic region, Calcineurin inhibitors (CNIs) may lead to diabetes, clinical assessment can be defined by urine output, Toxicity can lead to CV death, Efficacy is assessed by Acute rejection events, Chronic Allograft Nephropathy (CAN) consists of heterogeneous histopathologic findings, Gender can be Male, Acute rejection is represented by Acute rejection events, negative is a risk factor for development of PTLD (post-transplant lymphoproliferative disorder), Calcineurin inhibitors (CNIs) can have high Toxicity, Efficacy is assessed by Renal impairment, Calcineurin inhibitors (CNIs) may lead to lipid abnormalities, Acute rejection is associated with loss to follow up, Chronic Allograft Nephropathy (CAN) is determined by biopsy, Recipient EBV serology can be unknown